Literature DB >> 15756142

Etiological factor of hepatocellular carcinoma in Italy.

T Stroffolini1.   

Abstract

Cirrhosis from any cause is present in the majority (93.1%) of hepatocellular carcinoma (HCC) cases in Italy, it seems to be the common pathway by which several risk factors extent their carcinogenic effect. The mortality rate of HCC in Italy has progressively increased during the period 1969-1994, reflecting the rising number of persons living with cirrhosis as consequence of the remarkable advances in medical management of such patients. Most HCC develops in cirrhosis caused by known and preventable risk factors (hepatitis B virus, HBV, hepatitis C virus, HCV, alcohol and possibly non-alcoholic steatohepatitis, NASH). Unlike alcohol and NASH, HBV and HCV chronic infections act as a risk factors for HCC both because they induce cirrhosis and because they increase the risk in patients with cirrhosis. Moreover, case-control and prospective studies have shown a synergistic effect on HCC risk, when both viral infections occur. Currently, HCV infection is detected in the majority (76.4%) of HCC cases in Italy, reflecting the large cohort of subjects infected with this virus via the iatrogenic route during the 1950s and 1960s. The low rate of HCV infection in the younger Italian generations may generate a downward trend in the HCC mortality rate in the years to come.

Entities:  

Mesh:

Year:  2005        PMID: 15756142

Source DB:  PubMed          Journal:  Minerva Gastroenterol Dietol        ISSN: 1121-421X


  7 in total

1.  DNA repair gene XRCC3 Thr241Met polymorphism and hepatocellular carcinoma risk.

Authors:  Chenyang Duan; Wanli Zhang; Jiangfeng Lu; Huawen Wu; Mengying Liu; Wentao Zhu
Journal:  Tumour Biol       Date:  2013-07-04

2.  Epidemiology and survival of patients with hepatocellular carcinoma in Southern Germany.

Authors:  Gabriele Kirchner; Georgi Kirovski; Alexandra Hebestreit; Jürgen Schölmerich; Hans Jürgen Schlitt; Oliver Stoeltzing; Claus Hellerbrand
Journal:  Int J Clin Exp Med       Date:  2010-06-10

Review 3.  HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality.

Authors:  Nikolai Mühlberger; Ruth Schwarzer; Beate Lettmeier; Gaby Sroczynski; Stefan Zeuzem; Uwe Siebert
Journal:  BMC Public Health       Date:  2009-01-22       Impact factor: 3.295

4.  Epidemiology of hepatitis C: related hepatocellular carcinoma in Cameroon.

Authors:  Firmin Ankouane Andoulo; Dominique Noah Noah; Roger Djapa; Mathurin Kowo; Paul Talla; Edith Hell Medjo; Isidore Kamsi Djomkam; Bernadette Ngo Nonga; Oudou Njoya; Elie Claude Ndjitoyap Ndam
Journal:  Pan Afr Med J       Date:  2014-12-15

5.  Clinical Presentation, Risk Factors, and Treatment Modalities of Hepatocellular Carcinoma: A Single Tertiary Care Center Experience.

Authors:  Abdulrahman A Aljumah; Hadi Kuriry; Mohammed AlZunaitan; Mohammed Al Ghobain; Mohamed Al Muaikeel; Ashwaq Al Olayan; Fahad Azzumeea; Bader Almutairi; Abduljaleel AlAlwan; Hamdan AlGhamdi
Journal:  Gastroenterol Res Pract       Date:  2016-07-25       Impact factor: 2.260

6.  Diagnostic and Prognostic Role of Serum Interleukin-6 in Malignant Transformation of Liver Cirrhosis.

Authors:  Mustafa Yakut; Hasan Özkan; Muhammed F Karakaya; Harun Erdal
Journal:  Euroasian J Hepatogastroenterol       Date:  2018-05-01

7.  Nonalcoholic Cirrhosis Increased Risk of Digestive Tract Malignancies: A Population-Based Cohort Study.

Authors:  Li-Min Sun; Ming-Chia Lin; Cheng-Li Lin; Ji-An Liang; Long-Bin Jeng; Chia-Hung Kao; Chiao-Yi Lu
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.